Baker Avenue Asset Management, LP Cardiol Therapeutics Inc. Transaction History
Baker Avenue Asset Management, LP
- $5.03 Billion
- Q3 2025
A detailed history of Baker Avenue Asset Management, LP transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 45,402 shares of CRDL stock, worth $47,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,402Holding current value
$47,672% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
6.74MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X02.63MShares$2.76 Million1.47% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$900,2570.22% of portfolio
-
Lion Street Advisors, LLC340KShares$357,0260.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$307,7080.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$297,6451.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $65M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...